Nvidia Corporation <NVDA.O>: JPMorgan raises target price to $320 from $280
NVDA•Related News
AstraZeneca's asthma drug Tezspire meets all goals in late-stage esophagitis trial
AZN•
Veeva Systems Inc. <VEEV.N>: RBC Raises Target Price to $325 From $275
VEEV•
SEALSQ unit IC’Alps advances QASIC roadmap for quantum-resistant ASICs
LAES•
GRAPHIC-Six months of war: How the Middle East conflict has shaped financial markets
SPY•
China stocks climb on Nvidia-led AI hardware rally; Hong Kong lags
FXI•